This inventor holds 1 USPTO granted patent. Top assignee: Pharma Mar, S.a.. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: Ganit Koren-Goldshlager: Innovator in Antitumor Compounds
Introduction
Ganit Koren-Goldshlager is a notable inventor based in Tel Aviv, Israel. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with antitumor activity. His work is characterized by a focus on cytotoxic alkaloids, which are crucial in cancer treatment.
Latest Patents
Ganit holds a patent for cytotoxic alkaloids halitulin, which includes compounds of general formula (I). The nature of the group R in these compounds is not particularly critical and can take various forms. The natural compound halitulin, which he has worked on, demonstrates antitumor activity, showcasing the potential for therapeutic applications in oncology.
Career Highlights
Ganit is currently associated with Pharma Mar, S.A., a company known for its innovative approach to cancer treatment. His work at Pharma Mar has allowed him to explore and develop new therapeutic compounds that can significantly impact patient care.
Collaborations
Ganit collaborates with esteemed colleagues such as Maria Dolores Garcia Gravalos and Yoel Kashman. These partnerships enhance the research and development efforts within the company, fostering an environment of innovation and discovery.
Conclusion
Ganit Koren-Goldshlager is a prominent figure in the field of pharmaceutical innovation, particularly in the development of antitumor compounds. His contributions through patents and collaborations continue to advance cancer treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile